Response to Hepatitis B Vaccine in Egyptian Chronic Hepatitis C Patients

Biochemical study on the response to HCV therapy (Velpatasvir containing regimen), (vosevi) among adult patients’ non-responders to treatment in Fayoum Egypt

Interleukin 28B Polymorphism as a Predictor of Response to Treatment of Egyptian HCV Patients Working in Nuclear Material Authority

GENOTYPING STUDY ON HEPATITIS B VIRUS AMONG EGYPTIAN PATIENTS

Efficacy and safety of Tenofovir Disoproxil Fumarate in Egyptian patients with chronic hepatitis B virus infection

INTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.

The effect of the polymorphism in IL-28B gene on the treatment response of a combined therapy by sofosbuvir and daclatasvir with and without ribavirin in HCV Egyptian patients

The Effect of Direct Acting Antiviral Therapy for Hepatitis C- Virus Infected Egyptian Patients on Changes in the Parameters of Liver Fibrosis Progression

Vitamin D Profile : Can it Affect the Response to Standard Hepatitis C Treatment in Egyptian Patients ?

Impact of Hepatic Steatosis on Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C